JP2017517255A5 - - Google Patents

Download PDF

Info

Publication number
JP2017517255A5
JP2017517255A5 JP2016568573A JP2016568573A JP2017517255A5 JP 2017517255 A5 JP2017517255 A5 JP 2017517255A5 JP 2016568573 A JP2016568573 A JP 2016568573A JP 2016568573 A JP2016568573 A JP 2016568573A JP 2017517255 A5 JP2017517255 A5 JP 2017517255A5
Authority
JP
Japan
Prior art keywords
particles
micronized
diameter
jelly
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016568573A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017517255A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/032078 external-priority patent/WO2015179711A1/en
Publication of JP2017517255A publication Critical patent/JP2017517255A/ja
Publication of JP2017517255A5 publication Critical patent/JP2017517255A5/ja
Priority to JP2020096350A priority Critical patent/JP7304316B2/ja
Pending legal-status Critical Current

Links

JP2016568573A 2014-05-21 2015-05-21 微粉化ホウォートンゼリー Pending JP2017517255A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2020096350A JP7304316B2 (ja) 2014-05-21 2020-06-02 微粉化ホウォートンゼリー

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462001600P 2014-05-21 2014-05-21
US62/001,600 2014-05-21
PCT/US2015/032078 WO2015179711A1 (en) 2014-05-21 2015-05-21 Micronized wharton's jelly

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020096350A Division JP7304316B2 (ja) 2014-05-21 2020-06-02 微粉化ホウォートンゼリー

Publications (2)

Publication Number Publication Date
JP2017517255A JP2017517255A (ja) 2017-06-29
JP2017517255A5 true JP2017517255A5 (enExample) 2018-06-14

Family

ID=54554801

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016568573A Pending JP2017517255A (ja) 2014-05-21 2015-05-21 微粉化ホウォートンゼリー
JP2020096350A Active JP7304316B2 (ja) 2014-05-21 2020-06-02 微粉化ホウォートンゼリー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020096350A Active JP7304316B2 (ja) 2014-05-21 2020-06-02 微粉化ホウォートンゼリー

Country Status (5)

Country Link
US (1) US20150335686A1 (enExample)
EP (1) EP3146039A4 (enExample)
JP (2) JP2017517255A (enExample)
AU (2) AU2015264025A1 (enExample)
WO (1) WO2015179711A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101316602B (zh) 2005-09-27 2015-06-03 组织技术公司 羊膜制品和纯化的组合物及其使用方法
US9526770B2 (en) 2011-04-28 2016-12-27 Tissuetech, Inc. Methods of modulating bone remodeling
EP2717888B1 (en) 2011-06-10 2020-09-09 Tissuetech, Inc. Methods of processing fetal support tissues
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
US20160008410A1 (en) 2014-07-08 2016-01-14 Mimedx Group, Inc. Micronized wharton's jelly
US10201573B1 (en) * 2014-10-27 2019-02-12 Brahm Holdings, Llc Human birth tissue material composition and methods for the treatment of damage associated with a cerebral vascular accident
US20160243288A1 (en) 2015-02-23 2016-08-25 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
TWI720984B (zh) 2015-05-20 2021-03-11 美商帝聖工業公司 用於防止上皮細胞增生及上皮-間質轉移之組合物及方法
US12551509B2 (en) 2015-11-18 2026-02-17 Lucina Patent Holdco, Llc Acellular regenerative products and methods of their manufacture
US10420802B2 (en) 2015-12-10 2019-09-24 Aesthetics Biomedical, Inc. Topical formulation for skin care
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
CN109219442A (zh) 2016-04-04 2019-01-15 Omeza有限公司 鱼油局部组合物
CA3029233A1 (en) * 2016-06-24 2017-12-28 Osiris Therapeutics, Inc. Human tissue derived compositions and uses thereof
FR3070262B1 (fr) 2017-08-23 2020-10-16 Tbf Genie Tissulaire Tbf Composition comprenant de la gelee de wharton, procede de preparation et utilisations
US10251917B1 (en) 2017-09-19 2019-04-09 Gary M. Petrucci Methods and materials for treating tumors
EP3684382A4 (en) * 2017-09-19 2021-06-09 Gary M. Petrucci AMNION TISSUE PREPARATIONS AND METHOD OF USE
US11246994B2 (en) 2017-10-19 2022-02-15 Lifecell Corporation Methods for introduction of flowable acellular tissue matrix products into a hand
EP4309686A3 (en) * 2017-10-19 2024-02-07 LifeCell Corporation Flowable acellular tissue matrix products and methods of production
JP2022543362A (ja) * 2019-08-08 2022-10-12 ティシュー リジェネレイション セラピューティックス、インコーポレイテッド 血管周囲溶解物及びその使用
WO2021183851A1 (en) * 2020-03-12 2021-09-16 Osiris Therapeutics, Inc. Human tissue derived compositions and uses thereof
US11844876B2 (en) 2021-01-25 2023-12-19 BioStem Tehcnologies, Inc. Two-part clotting composition and methods of making and using thereof
EP4511046A4 (en) * 2022-04-20 2026-04-01 Biostem Tech Inc Human amniotic composition processed in several parts and its processes of manufacture and use for the treatment of Peyronie's disease
EP4561595A2 (en) * 2022-07-26 2025-06-04 Biostem Technologies, Inc. Human umbilical cord compositions and methods for intra-articular therapy
US20240226181A1 (en) * 2023-01-11 2024-07-11 Biostem Technologies, Inc. Human umbilical cord composition for treatment of peyronie's disease

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453638A1 (fr) * 1979-04-10 1980-11-07 Bontemps Raymond Produits cosmetiques exempts de tout excipient et de tout conservateur et applicables a l'etat congele
US20060074182A1 (en) * 2004-09-30 2006-04-06 Depuy Products, Inc. Hydrogel composition and methods for making the same
US9005646B2 (en) * 2005-10-12 2015-04-14 Lifenet Health Compositions for repair of defects in tissues, and methods of making the same
WO2008021391A1 (en) * 2006-08-15 2008-02-21 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
US8071135B2 (en) * 2006-10-04 2011-12-06 Anthrogenesis Corporation Placental tissue compositions
CA2739166C (en) * 2008-10-10 2013-12-31 Julio Font Perez New biomaterial from wharton's jelly of the human umbilical cord
CN102198292B (zh) * 2010-03-26 2013-06-26 卢世璧 组织工程用脐带去细胞Wharton胶支架及其制备方法
JP5591995B2 (ja) * 2010-03-30 2014-09-17 イストセル,エセ.エレ. ウォートンジェリー臍帯由来の新規の生体材料
WO2012112410A2 (en) * 2011-02-14 2012-08-23 Mimedx Group Inc. Micronized placental tissue compositions and methods for making and using the same
CA2826433C (en) * 2011-02-14 2022-05-31 Brenda S. Morse Micronized placental tissue compositions and methods of making and using the same
US12290613B2 (en) * 2011-10-06 2025-05-06 Mimedx Group, Inc. Micronized compositions composed of bone grafts and methods of making and using the same
PL3321355T3 (pl) * 2011-12-30 2021-12-27 Amit Patel Sposoby i kompozycje do klinicznego pozyskiwania komórek alogenicznych oraz zastosowania terapeutyczne
US11338063B2 (en) * 2012-08-15 2022-05-24 Mimedx Group, Inc. Placental tissue grafts modified with a cross-linking agent and methods of making and using the same
CA2880157C (en) * 2012-08-15 2020-07-21 Mimedx Group, Inc. Reinforced placental tissue grafts and methods of making and using the same
US9943551B2 (en) * 2012-08-15 2018-04-17 Mimedx Group, Inc. Tissue grafts composed of micronized placental tissue and methods of making and using the same
US8904664B2 (en) * 2012-08-15 2014-12-09 Mimedx Group, Inc. Dehydration device and methods for drying biological materials
JP2016529070A (ja) * 2013-09-10 2016-09-23 ミメディクス グループ インコーポレイテッド 成形胎盤組成物の美容的使用

Similar Documents

Publication Publication Date Title
AU2015287920A8 (en) Micronized Wharton's Jelly
JP2006181365A (ja) 半合成の血小板ゲル及びその調製方法
US9814746B2 (en) Method of treatment utilizing an acellular amnion derived therapeutic composition
JP2019509387A (ja) ジェランガムヒドロゲル、調製物、方法、およびそれらの使用
JP2016216487A5 (enExample)
JP2019513136A5 (enExample)
ME02868B (me) POSTUPCI, CEV, l UREĐAJ ZA DOBIJANJE KOMPOZICIJE ZA ZARASTANJE RANA
JP2013527217A5 (enExample)
WO2013096792A1 (en) Method for repairing or replacing damaged tissue
MX388111B (es) Metodo y composicion para producir agentes regenerativos anti-inflamatorios/anti-catabolicos mejorados a partir de fluido fisiologico autologo.
CN103446624A (zh) 载药微球/壳聚糖/海藻酸钠可注射水凝胶的制备方法
WO2010082787A3 (ko) 연골줄기세포를 유효성분으로 포함하는 골질환 치료용 또는 항염증용 약제학적 조성물
HRP20161138T1 (hr) Farmaceutski pripravak za oralnu primjenu
JP2021500092A5 (enExample)
JP2017507145A5 (enExample)
Zhang et al. Mesenchymal stem cells-based drug delivery systems for diabetic foot ulcer: A review
JP2013173780A5 (enExample)
US20190022136A1 (en) Micron-sized gold, kit comprising said gold and its use as a non-toxic immune suppressor as well as gold implants
RU2017129375A (ru) Интестинальный гель на основе леводопы и карбидопы и способы его применения
JP2013520271A5 (enExample)
MX380536B (es) Composicion y metodo para tratar la enfermedad de chagas.
CN104524633B (zh) 一种基于肌肉的神经支架及其制备方法
US20190343983A1 (en) Scaffold compositions for tissue repair
RU2015133365A (ru) Альфа-2 адренергический агонист для лечения внутриглазного давления и заболеваний глаз путем введения в стекловидное тело и внутрикамерно
US20220143268A1 (en) Novel bone putty compositions and methods of use thereof